Document is current
Any future updates will be listed below
-
Authors
Visentin, Andrea https://orcid.org/0000-0003-0271-7200
Gaffo, Enrico https://orcid.org/0000-0001-6338-7677
Fürstenau, Moritz https://orcid.org/0000-0002-6593-0140
Rogers, Kerry A.
Panagiotis, Baliakas https://orcid.org/0000-0002-5634-7156
Cui, Chenghua
Miller, Cecelia https://orcid.org/0000-0001-6110-6069
Haferlach, Claudia https://orcid.org/0000-0002-6333-5049
Plevova, Karla https://orcid.org/0000-0002-6148-8877
Oscier, David https://orcid.org/0000-0001-8486-2051
Davis, Zadie https://orcid.org/0000-0001-6959-4853
Nguyen-Khac, Florence
Roncaglia, Eleonora
Rigolin, Gian Matteo https://orcid.org/0000-0002-8370-5190
Athanasiadou, Anastasia
Baran-Marszak, Fanny https://orcid.org/0000-0002-3723-2927
Valiente, Alberto
Terol, Maria José
Abrisqueta, Pau
Espinet, Blanca https://orcid.org/0000-0002-4294-8145
Puiggros, Anna
Martines, Annalisa https://orcid.org/0000-0002-4701-8457
Bonaldi, Laura
Mauro, Francesca Romana https://orcid.org/0000-0003-2425-9474
Scarfò, Lydia https://orcid.org/0000-0002-0844-0989
Chatzikonstantinou, Thomas https://orcid.org/0000-0003-4105-1253
Tausch, Eugen
Kreuzer, Karl-Anton
Kater, Arnon https://orcid.org/0000-0003-3190-1891
Bosch, Francesc
Doubek, Michael
Panagiotidis, Panagiotis
Kalashnikova, Olga https://orcid.org/0000-0002-1856-1055
Frezzato, Federica https://orcid.org/0000-0001-7093-2493
Calabretto, Giulia
Ruocco, Valeria
Orsi, Silvia https://orcid.org/0009-0009-8860-5875
Cellini, Alessandro
Angotzi, Francesco
Serafin, Andrea
Yi, Shuhua https://orcid.org/0000-0002-6291-812X
Eichhorst, Barbara
Woyach, Jennifer A. https://orcid.org/0000-0002-3403-9144
Cuneo, Antonio
Ghia, Paolo https://orcid.org/0000-0003-3750-7342
Stamatopoulos, Kostas https://orcid.org/0000-0001-8529-640X
Trentin, Livio https://orcid.org/0000-0003-1222-6149
Bortoluzzi, Stefania https://orcid.org/0000-0001-8240-3070
- License Information
-
More Information
Article History
Received: 20 May 2025
Revised: 28 July 2025
Accepted: 27 August 2025
First Online: 19 September 2025
Competing interests
: AV, LT PG, LS, and FRM attended scientific boards organized by Johnson & Johnson, AstraZeneca, BeiGene, and AbbVie. PG received honoraria from AbbVie, AstraZeneca, BeiGene, BMS, Galapagos, Johnson & Johnson, Lilly/Loxo, MSD, and research funding from AbbVie, AstraZeneca, BeiGene, BMS, Johnson & Johnson, Lilly/Loxo, MSD. LyS received honoraria from AbbVie, AstraZeneca, BeiGene, Johnson & Johnson, Lilly, and MSD. G.M.R. received honoraria for participation in the speakers’ bureau and advisory board from AbbVie, AstraZeneca, and Janssen. A.C. received honoraria for participation in the speakers’ bureau and advisory board from AbbVie, AstraZeneca, BeiGene, and Janssen Lilly. MD Advisory boards and honoraria: AbbVie, AstraZeneca, Eli Lilly, Johnson and Johnson, Swixx Biopharma. The other authors declared no potential conflict of interest with this study.
: The study was conducted in accordance with the Declaration of Helsinki, approved by the Ethics Committee of Padova University Hospital (protocol #4430/AO/18), and informed consent was obtained.
